Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Salophen iron chelate is a synthetic coordination compound consisting of an iron ion complexed with the tetradentate Schiff base ligand salophen (N,N′-bis(salicylidene)-1,2-phenylenediamine). It is classified as a small molecule and has been investigated primarily as an experimental agent. Salophen iron chelate acts as a metal-chelating agent and has potential therapeutic applications in treating conditions related to iron overload and possibly cancer. Its mechanism involves binding to free or excess iron ions in biological systems through strong coordination bonds formed by the ligand's nitrogen and oxygen donor atoms. This sequestration of free iron may reduce oxidative stress or modulate cellular processes dependent on available metal ions. The compound is not approved for clinical use but remains of interest for research into novel chelation therapies and anti-cancer strategies[1][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on salophen iron chelate.